Abstract
Altered extracellular matrix (ECM) deposition contributing to airway wall remodeling is an important feature of asthma and chronic obstructive pulmonary disease (COPD). The molecular mechanisms of this process are poorly understood. One of the key pathological features of these diseases is thickening of airway walls. This thickening is largely to the result of airway smooth muscle (ASM) cell hyperplasia and hypertrophy as well as increased deposition of ECM proteins such as collagens, elastin, laminin, and proteoglycans around the smooth muscle. Many growth factors and cytokines, including fibroblast growth factor (FGF)-1, FGF-2, and transforming growth factor (TGF)-α1, that are released from the airway wall have the potential to contribute to airway remodeling, revealed by enhanced ASM proliferation and increased ECM protein deposition. TGF-α1 and FGF-1 stimulate mRNA expression of collagen I and III in ASM cells, suggesting their role in the deposition of extracellular matrix proteins by ASM cells in the airways of patients with chronic lung diseases. Focus is now on the bidirectional relationship between ASM cells and the ECM. In addition to increased synthesis of ECM proteins, ASM cells can be involved in downregulation of matrix metalloproteinases (MMPs) and upregulation of tissue inhibitors of metalloproteinases (TIMPs), thus eventually contributing to the alteration in ECM. In turn, ECM proteins promote the survival, proliferation, cytokine synthesis, migration, and contraction of human airway smooth muscle cells. Thus, the intertwined relationship of ASM and ECM and their response to stimuli such as chronic inflammation in diseases such as asthma and COPD contribute to the remodeling seen in airways of patients with these diseases.
Similar content being viewed by others
References
Black, J. and Page, C. (1994) Airways and vascular remodelling in asthma and cardiovascular disease: implications for therapeutic intervention. Eur. Respir. J. 7, 622–623.
Jeffery, P. K. (2001) Remodeling in asthma and chronic obstructive lung disease. Am. J. Respir. Crit. Care Med. 164, S28-S38.
Lambert, R. K. (1991) Role of bronchial basement membrane in airway collapse. J. Appl. Physiol. 71, 666–673.
Roche, W. R., Beasley, R., Williams, J. H., and Holgate, S. T. (1989) Subepithelial fibrosis in the bronchi of asthmatics. Lancet 1, 520–524.
Laitinen, A., Altraja, A., Kampe, M., Linden, M., Virtanen, I., and Laitinen, L. A. (1997) Tenascin is increased in airway basement membrane of asthmatics and decreased by an inhaled steroid. Am. J. Respir. Crit. Care Med. 156, 951–958.
Roberts, C. R. and Burke, A. K. (1998) Remodelling of the extracellular matrix in asthma: proteoglycan synthesis and degradation. Can. Respir. J. 5, 48–50.
Johnson, P. R., Black, J. L., Carlin, S., Ge, Q., and Underwood, P. A. (2000) The production of extracellular matrix proteins by human passively sensitized airway smooth-muscle cells in culture: the effect of beclomethasone. Am. J. Respir. Crit. Care Med. 162, 2145–2151.
Elshaw, S. R., Henderson, N., Knox, A. J., Watson, S. A., Buttle, D. J., and Johnson, S. R. (2004) Matrix metalloproteinase expression and activity in human airway smooth muscle cells. Br. J. Pharmacol. 142, 1318–1324.
McKay, S., de Jongste, J. C., Saxena, P. R., and Sharma, H. S. (1998) Angiotensin II induces hypertrophy of human airway smooth muscle cells: expression of transcription factors and transforming growth factor-α1 Am. J. Respir. Cell Mol. Biol. 18, 823–833.
Burgess, J. K., Johnson, P. R., et al. (2003) Expression of connective tissue growth factor in asthmatic airway smooth muscle cells. Am. J. Respir. Crit. Care Med. 167, 71–77.
Giancotti, F. G. and Ruoslahti, E. (1999) Integrin signaling. Science 285, 1028–1032.
Aplin, A. E., Howe, A., Alahari, S. K., and Juliano, R. L. (1998) Signal transduction and signal modulation by cell adhesion receptors: the role of integrins, cadherins, immunoglobulin-cell adhesion molecules, and selectins. Pharmacol. Rev. 50, 197–263.
Giancotti, F. G. (2000) Complexity and specificity of integrin signalling. Nat. Cell Biol. 2, E13-E14.
Belkin, A. M. and Stepp, M. A. (2000) Integrins as receptors for laminins. Microsc. Res. Tech. 51, 280–301.
Spofford, C. M., and Chilian, W. M. (2001) The elastinlaminin receptor functions as a mechanotransducer in vascular smooth muscle. Am. J. Physiol. 280, H1354-H1360.
Kranenburg, A. R., Willems-Widyastuti, A., Saxena, P. R., Sterk, P. J., de Boer, W. I., and Sharma, H. S. (2002) Enhanced pulmonary expression of extracellular matrix proteins in central airways of COPD patients. Am. J. Respir. Crit. Care Med. 165, A600.
Howarth, P. H., Knox, A. J., Amrani Y., et al. (2004) Synthetic responses in airway smooth muscle. J. Allergy Clin. Immunol. 114, S32-S50.
Black, J. L., Burgess, J. K., and Johnson, P. R. (2003) Airway smooth muscle—its relationship to the extracellular matrix. Respir. Physiol. Neurobiol. 137, 339–346.
Panettieri, R. A., Tan, E. M., Ciocca, V., Luttmann, M. A., Leonard, T. B., and Hay, D. W. (1998) Effects of LTD4 on human airway smooth muscle cell proliferation, matrix expression, and contraction in vitro: differential sensitivity to cysteinyl leukotriene receptor antagonists. Am. J. Respir. Cell Mol. Biol. 19, 453–461.
Billings, P. C., Herrick, D. J., Howard, P. S., Kucich, U., Engelsberg, B. N., and Rosenbloom, J. (2000) Expression of βIG-h3 by human bronchial smooth muscle cells: localization To the extracellular matrix and nucleus. Am. J. Respir. Cell Mol. Biol. 22, 352–359.
Black, P. N., Young, P. G., and Skinner, S. J. (1996) Response of airway smooth muscle cells to TGF-α1 effects on growth and synthesis of glycosaminoglycans. Am. J. Physiol. 271, L910-L917.
Foda, H. D., George, S., Rollo, E., et al. (1999) Regulation of gelatinases in human airway smooth muscle cells: mechanism of progelatinase A activation. Am. J. Physiol. 277, L174-L182.
Johnson, S. and Knox, A. (1999) Autocrine production of matrix metalloproteinase-2 is required for human airway smooth muscle proliferation. Am. J. Physiol. 277, L1109-L1117.
Imai, K., Hiramatsu, A., Fukushima, D., Pierschbacher, M.D., and Okada, Y. (1997) Degradation of decorin by matrix metalloproteinases: identification of the cleavage sites, kinetic analyses and transforming growth factor-α1 release. Biochem. J. 322, 809–814.
Coutts, A., Chen, G., Stephens, N., et al. (2001) Release of biologically active TGF-α1 from airway smooth muscle cells induces autocrine synthesis of collagen. Am. J. Physiol. 280, L999-L1008.
Khalil, N., Corne, S., Whitman, C., and Yacyshyn, H. (1996) Plasmin regulates the activation of cell-associated latent TGF-α1 secreted by rat alveolar macrophages after in vivo bleomycin injury. Am. J. Respir. Cell Mol. Biol. 15, 252–259.
Khalil, N., O'Connor, R. N., Flanders, K. C., and Unruh, H. (1996) TGF-α1 but not TGF-α2 or TGF-α3 is differentially present in epithelial cells of advanced pulmonary fibrosis: an immunohistochemical study. Am. J. Respir. Cell Mol. Biol. 14, 131–138.
Johnson, P. R. (2001) Role of human airway smooth muscle in altered extracellular matrix production in asthma. Clin. Exp. Pharmacol. Physiol. 28, 233–236.
Kranenburg, A. R., Willems-Widyastuti, A., Saxena, P. R., Sterk, P. J., de Boer, W. I., and Sharma, H. S. (2003) Fibroblast growth factors differentially induce mRNA expression of collagens and fibronectin and secretion of transforming growth factor-b1 in cultured human airway smooth muscle cells. Am. J. Respir. Crit. Care Med. 167, A690.
Pickering, J. G., Ford, C. M., Tang, B., and Chow, L. H. (1997) Coordinated effects of fibroblast growth factor-2 on expression of fibrillar collagens, matrix metalloproteinases, and tissue inhibitors of matrix metalloproteinases by human vascular smooth muscle cells. Evidence for repressed collagen production and activated degradative capacity. Arterioscler. Thromb. Vasc. Biol. 17, 475–482.
Kranenburg, A. R., De Boer, W. I., Van Krieken, J. H., et al. (2002) Enhanced expression of fibroblast growth factors and receptor FGFR-1 during vascular remodeling in chronic obstructive pulmonary disease. Am. J. Respir. Cell Mol. Biol. 27, 517–525.
Freyer, A. M., Johnson, S. R., and Hall, I. P. (2001) Effects of growth factors and extracellular matrix on survival of human airway smooth muscle cells. Am. J. Respir. Cell Mol. Biol. 25, 569–576.
Hirst, S. J., Twort, C. H., and Lee, T. H. (2000) Differential effects of extracellular matrix proteins on human airway smooth muscle cell proliferation and phenotype. Am. J. Respir. Cell Mol. Biol. 23, 335–344.
Bonacci, J. V., Harris, T., Wilson, J. W., and Stewart, A. G. (2003) Collagen-induced resistance to glucocorticoid antimitogenic actions: a potential explanation of smooth muscle hyperplasia in the asthmatic remodelled airway. Br. J. Pharmacol. 138, 1203–1206.
Freyer, A. M., Billington, C. K., Penn, R. B., and Hall, I. P. (2004) Extracellular matrix modulates \eta²-adrenergic receptor signaling in human airway smooth muscle cells. Am. J. Respir. Cell Mol. Biol. 31, 440–445.
Ghaffar, O., Hamid, Q., Renzi, P. M., et al. (1999) Constitutive and cytokine-stimulated expression of eotaxin by human airway smooth muscle cells. Am. J. Respir. Crit. Care Med. 159, 1933–1942.
Ying, S., Meng, Q., Zeibecoglou, K., et al. (1999) Eosinophil chemotactic chemokines (eotaxin, eotaxin-2, RANTES, monocyte chemoattractant protein-3 (MCP-3), and MCP-4), and C−C chemokine receptor 3 expression in bronchial biopsies from atopic and nonatopic (Intrinsic) asthmatics. J. Immunol. 163, 6321–6329.
Chung, K. F., Patel, H. J., Fadlon, E. J., et al. (1999) Induction of eotaxin expression and release from human airway smooth muscle cells by IL-α1 and TNF-α effects of IL-10 and corticosteroids. Br. J. Pharmacol. 127, 1145–1150.
Moore, P. E., Church, T. L., Chism, D. D., Panettieri, R. A., Jr., and Shore, S. A. (2002) IL-13 and IL-4 cause eotaxin release in human airway smooth muscle cells: a role for ERK. Am. J. Physiol. 282, L847-L853.
Peng, Q., Lai, D., Nguyen, T. T., Chan, V., Matsuda, T., and Hirst, S. J. (2005) Multiple beta 1 integrins mediate enhancemant of human airway smooth muscle cytokine secretion by fibronectin and type I collagen. J. Immunol. 174, 2258–2264.
Ebina, M., Takahashi, T., Chiba, T., and Motomiya, M. (1993) Cellular hypertrophy and hyperplasia of airway smooth muscles underlying bronchial asthma. A 3-D morphometric study. Am. Rev. Respir. Dis. 148, 720–726.
Parameswaran, K., Cox, G., Radford, K., Janssen, L. J., Sehmi, R., and O'Byrne, P. M. (2002) Cysteinyl leukotrienes promote human airway smooth muscle migration. Am. J. Respir. Crit. Care Med. 166, 738–742.
Parameswaran, K., Radford, K., Zuo, J., Janssen, L. J., O'Byrne, P. M., and Cox, P. G. (2004) Extracellular matrix regulates human airway smooth muscle cell migration. Eur. Respir. J. 24, 545–551.
Krymskaya, V. P., Goncharova, E. A., Ammit, A. J., et al. (2005) Src is necessary and sufficient for human airway smooth muscle cell proliferation and migration. FASEB J. 19, 428–430.
Schenk, S. and Quaranta, V. (2003) Tales from the crypt[ic] sites of the extracellular matrix. Trends Cell Biol. 13, 366–375.
Chakir, J., Shannon, J., Molet, S., et al. (2003) Airway remodeling-associated mediators in moderate to severe asthma: effect of steroids on TGF-beta, IL-11, IL-17, and type I and type III collagen expression. J. Allergy Clin. Immunol. 111, 1293–1298.
Ward, J. E., Gould, H., Harris, T., Bonacci, J. V., and Stewart, A. G. (2004) PPAR gamma ligands, 15-deoxy-delta12,14-protaglandin J2 and rosiglitazone regulate human cultured airway smooth muscle proliferation through different mechanisms. Br. J. Pharmacol. 141, 517–525.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Parameswaran, K., Willems-Widyastuti, A., Alagappan, V.K.T. et al. Role of extracellular matrix and its regulators in human airway smooth muscle biology. Cell Biochem Biophys 44, 139–146 (2006). https://doi.org/10.1385/CBB:44:1:139
Issue Date:
DOI: https://doi.org/10.1385/CBB:44:1:139